American Healthcare REIT, Inc.
AHR Real Estate Reit Healthcare Facilities
American Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 9.15% from fiscal 2024. In the quarter to June 2026, revenue grew 24.3%, EPS grew 166.7%, free cash flow grew 9.53% and total debt fell 7.97%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five.
Follow AHR
American Healthcare REIT, Inc. (AHR) EV/Sales
As of 16 October 2026, American Healthcare REIT, Inc. (AHR) trades at a EV/Sales of 4.6×. Over the past ten years it has ranged from 1.7× (April 2024) to 4.9× (July 2026); the current reading is higher than 91% of that period. That is below the Reit Healthcare Facilities industry median of 8.5× and below the Real Estate sector median of 7.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 4.1× | 59.42% |
| FY2024 | 2.6× | 42.46% |
| FY2023 | 1.8× | 0.00% |
| FY2022 | 1.8× | 0.00% |
| FY2021 | 1.8× | 0.00% |
| FY2020 | 1.8× | 0.00% |
| FY2019 | 1.8× | 0.00% |
| FY2018 | 1.8× | 0.00% |
| FY2017 | 1.8× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 4.5× | 4.72% |
| Mar 2026 | 4.3× | 5.80% |
| Dec 2025 | 4.1× | 5.81% |
| Sep 2025 | 3.9× | 13.54% |
| 36 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| AHR American Healthcare REIT, Inc. | 4.6× |
| HR Healthcare Realty Trust Incorporated compare | 5.3× |
| DOC Healthpeak Properties, Inc. compare | 7.3× |
| VTR Ventas, Inc. compare | 8.4× |
| SBRA Sabra Healthcare REIT, Inc. compare | 8.5× |
| LTC LTC Properties, Inc. compare | 8.6× |
| NHI National Health Investors, Inc. compare | 10.3× |
| OHI Omega Healthcare Investors, Inc. compare | 10.5× |
| CTRE CareTrust REIT, Inc. compare | 17.0× |
| Reit Healthcare Facilities industry median | 8.5× |
| Real Estate sector median | 7.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)